Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 5/2005

01.04.2005 | Original Article

Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer

verfasst von: Marco Maccauro, Giovanni Lucignani, Gianluca Aliberti, Carlo Villano, Maria Rita Castellani, Eugenio Solima, Emilio Bombardieri

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 5/2005

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to assess the feasibility of sentinel lymph node (SLN) detection in endometrial cancer patients with a dual-tracer procedure after hysteroscopic peritumoural injection.

Methods

Twenty-six women with previously untreated endometrial adenocarcinoma underwent the hysteroscopic injection of 111 MBq 99mTc-Nanocoll and blue dye administered subendometrially around the lesion. On the same day, all 26 patients underwent lymphoscintigraphy, followed 3–4 h later by hysterotomy with bilateral salpingo-oophorectomy and pelvic lymphadenectomy. Para-aortic lymphadenectomy was also performed in cases of either serous or papillary carcinoma (n=7/26). All SLNs were removed and examined with haematoxylin and eosin staining and immunohistochemical techniques.

Results

The procedure was well tolerated by patients, only two experiencing transient vagal symptoms. The sensitivity of this technique for correct identification of SLNs was 100%. Lymph node metastases were found in 4 out of the 26 patients (15%), bilaterally in the external iliac region (n=1), unilaterally in the external iliac region (n=1), unilaterally in the common iliac region (n=1) and unilaterally in the para-aortic region (n=1). In all four cases, nodal metastases were located within SLNs detected by lymphoscintigraphy. Only 10 of the 26 patients (38%) had significant blue dye staining. All blue-stained SLNs were radioactive.

Conclusion

In patients with endometrial cancer, it is feasible to use lymphatic mapping and SLN biopsy to define the topographic distribution of the lymphatic network and also to accurately detect lumbo-aortic and pelvic metastases within SLNs. In the majority of patients with early stage endometrial cancer, this procedure may avoid unnecessary radical pelvic lymphadenectomy. It may also guide para-aortic lymph node dissection on the basis of the SLN status.
Literatur
1.
Zurück zum Zitat Estourgie SH, Nieweg OE, Valdes Olmos RA, Hoefnagel CA, Kroon BB. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 2003;10:681–8.CrossRef Estourgie SH, Nieweg OE, Valdes Olmos RA, Hoefnagel CA, Kroon BB. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 2003;10:681–8.CrossRef
2.
Zurück zum Zitat Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546–53.CrossRefPubMed Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546–53.CrossRefPubMed
3.
Zurück zum Zitat Makar AP, Scheistroen M, van den Weyngaert D, Trope CG. Surgical management of stage I and stage II vulvar cancer: the role of the sentinel node biopsy. Review of literature. Int J Gynecol Cancer 2001;11:255–62.CrossRef Makar AP, Scheistroen M, van den Weyngaert D, Trope CG. Surgical management of stage I and stage II vulvar cancer: the role of the sentinel node biopsy. Review of literature. Int J Gynecol Cancer 2001;11:255–62.CrossRef
4.
Zurück zum Zitat Dargent D, Martin X, Mathevet P. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer. Gynecol Oncol 2000;79:411–5.CrossRefPubMed Dargent D, Martin X, Mathevet P. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer. Gynecol Oncol 2000;79:411–5.CrossRefPubMed
5.
Zurück zum Zitat Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 1991;78:63–9. Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 1991;78:63–9.
6.
Zurück zum Zitat Belinson JL, Lee KK, Badger GJ, Pretorius RG, Jarrell MA. Clinical stage I adenocarcinoma of the endometrium—analysis of recurrences and the potential benefit of staging lymphadenectomy. Gynecol Oncol 1992;44:17–23.CrossRef Belinson JL, Lee KK, Badger GJ, Pretorius RG, Jarrell MA. Clinical stage I adenocarcinoma of the endometrium—analysis of recurrences and the potential benefit of staging lymphadenectomy. Gynecol Oncol 1992;44:17–23.CrossRef
7.
Zurück zum Zitat Benedetti Panici PL, Scambia G, Baiocchi G, Greggi S, Mancuso S. Technique and feasibility of radical para-aortic and pelvic lymphadenectomy for gynaecologic malignancies: a prospective study. Int J Gynecol Cancer 1991;1:133–40. Benedetti Panici PL, Scambia G, Baiocchi G, Greggi S, Mancuso S. Technique and feasibility of radical para-aortic and pelvic lymphadenectomy for gynaecologic malignancies: a prospective study. Int J Gynecol Cancer 1991;1:133–40.
8.
Zurück zum Zitat Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gershenson DM. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: result of a pilot study. Gynecol Oncol 1996;62:169–73.CrossRef Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gershenson DM. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: result of a pilot study. Gynecol Oncol 1996;62:169–73.CrossRef
9.
Zurück zum Zitat Pelosi E, Arena V, Baudino B, Belló M, Giusti M, Gargiulo T, et al. Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl Med Commun 2003;24(9):971–5.CrossRef Pelosi E, Arena V, Baudino B, Belló M, Giusti M, Gargiulo T, et al. Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl Med Commun 2003;24(9):971–5.CrossRef
10.
Zurück zum Zitat Holub Z, Jabor A, Kliment L. Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. Eur J Gynecol Oncol 2002;23:53–7. Holub Z, Jabor A, Kliment L. Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. Eur J Gynecol Oncol 2002;23:53–7.
11.
Zurück zum Zitat Zambo K, Koppan M, Paal A, Schmidt E, Tinneberg HR, Bodis J. Sentinel lymph nodes in gynaecological malignancies: frontline between TNM and clinical staging system? Eur J Nucl Med Mol Imaging 2003;30(12):1684–8.CrossRef Zambo K, Koppan M, Paal A, Schmidt E, Tinneberg HR, Bodis J. Sentinel lymph nodes in gynaecological malignancies: frontline between TNM and clinical staging system? Eur J Nucl Med Mol Imaging 2003;30(12):1684–8.CrossRef
12.
Zurück zum Zitat Fersis N, Gruber I, Relakis K, Friedrich M, Becker S, Wallwiener D, et al. Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer. Eur J Gynaecol Oncol 2004;25(3):339–42. Fersis N, Gruber I, Relakis K, Friedrich M, Becker S, Wallwiener D, et al. Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer. Eur J Gynaecol Oncol 2004;25(3):339–42.
13.
Zurück zum Zitat Gargiulo T, Giusti M, Bottero A, Leo L, Brokaj L, Armellino F, et al. Sentinel lymph node (SLN) laparoscopic assessment early stage in endometrial cancer. Minerva Ginecol 2003;55(3):259–62. Gargiulo T, Giusti M, Bottero A, Leo L, Brokaj L, Armellino F, et al. Sentinel lymph node (SLN) laparoscopic assessment early stage in endometrial cancer. Minerva Ginecol 2003;55(3):259–62.
14.
Zurück zum Zitat Barranger E, Cortez A, Grahek D, Callard P, Uzan S, Darai E. Laparoscopic sentinel node procedure using a combination of patent blue and radiocolloid in women with endometrial cancer. Ann Surg Oncol 2004;11:344–9.CrossRef Barranger E, Cortez A, Grahek D, Callard P, Uzan S, Darai E. Laparoscopic sentinel node procedure using a combination of patent blue and radiocolloid in women with endometrial cancer. Ann Surg Oncol 2004;11:344–9.CrossRef
15.
Zurück zum Zitat Niikura H, Okamura C, Utsunomiya H, Yoshinaga K, Akahira J, Ito K, Yaegashi N. Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol 2004;92:669–74.CrossRef Niikura H, Okamura C, Utsunomiya H, Yoshinaga K, Akahira J, Ito K, Yaegashi N. Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol 2004;92:669–74.CrossRef
16.
Zurück zum Zitat Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546–53.CrossRefPubMed Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546–53.CrossRefPubMed
17.
Zurück zum Zitat Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with melanoma. J Nucl Med 1998;38:1185–90. Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with melanoma. J Nucl Med 1998;38:1185–90.
18.
Zurück zum Zitat Morton DL, Wen DR, Wong JH, Economu JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–9.PubMed Morton DL, Wen DR, Wong JH, Economu JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–9.PubMed
19.
Zurück zum Zitat Giuliano AE, Kirgan DM, Geunther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–401.PubMed Giuliano AE, Kirgan DM, Geunther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–401.PubMed
20.
Zurück zum Zitat Alex JC, Krag DN. Gamma probe-guide localization of lymph nodes. Surg Oncol 1993;2:137–43.CrossRef Alex JC, Krag DN. Gamma probe-guide localization of lymph nodes. Surg Oncol 1993;2:137–43.CrossRef
21.
Zurück zum Zitat Alex JC, Weaver DL, Fairbank JT, Rankin BS, Krag DN. Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol 1993;2:303–8.PubMed Alex JC, Weaver DL, Fairbank JT, Rankin BS, Krag DN. Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol 1993;2:303–8.PubMed
22.
Zurück zum Zitat Van der Veen H, Hoekstra OS, Paul MA, Cuesta MA, Meijer S. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 1994;81:1769–70. Van der Veen H, Hoekstra OS, Paul MA, Cuesta MA, Meijer S. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 1994;81:1769–70.
23.
Zurück zum Zitat Kapteijn BA, Nieweg OE, Liem I, Mooi WJ, Balm AJ, Muller SH, et al. Localizing the sentinel node in cutaneous melanoma: gamma-probe detection versus blue-dye. Ann Surg Oncol 1997;4:156–60. Kapteijn BA, Nieweg OE, Liem I, Mooi WJ, Balm AJ, Muller SH, et al. Localizing the sentinel node in cutaneous melanoma: gamma-probe detection versus blue-dye. Ann Surg Oncol 1997;4:156–60.
24.
Zurück zum Zitat Alazraki N, Glass EC, Castronovo F, Olmos RA, Podoloff D. Procedure guideline for lymphoscintigraphy and the use of intraoperative gamma probe for sentinel lymph node localization in melanoma of intermediate thickness 1.0. J Nucl Med 2002;43(10):1414–8. Alazraki N, Glass EC, Castronovo F, Olmos RA, Podoloff D. Procedure guideline for lymphoscintigraphy and the use of intraoperative gamma probe for sentinel lymph node localization in melanoma of intermediate thickness 1.0. J Nucl Med 2002;43(10):1414–8.
25.
Zurück zum Zitat Zanzonico P, Heller S. The intra-operative gamma probe: basic principles and choices available. Semin Nucl Med 2000;30:33–48. Zanzonico P, Heller S. The intra-operative gamma probe: basic principles and choices available. Semin Nucl Med 2000;30:33–48.
26.
Zurück zum Zitat Kopp J, Wengenmair H, Vogt H, Heidenreich P. Intra-operative gamma-probe: performance of commercially available systems- a comparison. Eur J Nucl Med 1999;26 Suppl 4:S59, S.03.04. Kopp J, Wengenmair H, Vogt H, Heidenreich P. Intra-operative gamma-probe: performance of commercially available systems- a comparison. Eur J Nucl Med 1999;26 Suppl 4:S59, S.03.04.
27.
Zurück zum Zitat FIGO news. Corpus cancer staging. Int J Obstet 1989;28:190. FIGO news. Corpus cancer staging. Int J Obstet 1989;28:190.
28.
Zurück zum Zitat Obermair A, Geramou M, Gucer F, Denison U, Graf AH, Kapshammer E, et al. Does hysteroscopy facilitate tumor cell dissemination? Cancer 2000;88:139–43. Obermair A, Geramou M, Gucer F, Denison U, Graf AH, Kapshammer E, et al. Does hysteroscopy facilitate tumor cell dissemination? Cancer 2000;88:139–43.
29.
Zurück zum Zitat Selvaggi L, Cormio G, Ceci O, Loverro G, Cazzolla A, Bettocchi S. Hysteroscopy does not increase the risk of microscopic extrauterine spread in endometrial carcinoma. Int J Gynecol Cancer 2003;13:223–7.CrossRef Selvaggi L, Cormio G, Ceci O, Loverro G, Cazzolla A, Bettocchi S. Hysteroscopy does not increase the risk of microscopic extrauterine spread in endometrial carcinoma. Int J Gynecol Cancer 2003;13:223–7.CrossRef
30.
Zurück zum Zitat Baker VL, Adamson GD. Threshold intrauterine perfusion pressures for intraperitoneal spill during hydrotubation and correlation with tubal adhesive disease. Fertil Steril 1995;64:1066–9. Baker VL, Adamson GD. Threshold intrauterine perfusion pressures for intraperitoneal spill during hydrotubation and correlation with tubal adhesive disease. Fertil Steril 1995;64:1066–9.
31.
Zurück zum Zitat Kasamatsu T, Onda T, Katsumata N, Sawada M, Yamada T, Tsunematsu R, et al. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer 2003;88:245–50.CrossRef Kasamatsu T, Onda T, Katsumata N, Sawada M, Yamada T, Tsunematsu R, et al. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer 2003;88:245–50.CrossRef
Metadaten
Titel
Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer
verfasst von
Marco Maccauro
Giovanni Lucignani
Gianluca Aliberti
Carlo Villano
Maria Rita Castellani
Eugenio Solima
Emilio Bombardieri
Publikationsdatum
01.04.2005
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 5/2005
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-004-1709-4

Weitere Artikel der Ausgabe 5/2005

European Journal of Nuclear Medicine and Molecular Imaging 5/2005 Zur Ausgabe